Minerva Neurosciences Inc (NERV) — Cash Flow Reinvestment Rate

Latest as of September 2017: 3.21x

Minerva Neurosciences Inc (NERV) has a Cash Flow Reinvestment Rate of 3.21x as of September 2017, reinvesting $79.80 Million (capex $0.00 plus investments $-79.80 Million) from operating cash flow of $24.89 Million. Explore NERV capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

3.21x
(Capex + Investments) / Operating CF

Total Reinvested

$79.80 Million
Capex + Investments

Operating Cash Flow

$24.89 Million
USD

Capital Expenditures

$0.00
USD

Minerva Neurosciences Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Minerva Neurosciences Inc across 1 annual periods. Also explore NERV asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Minerva Neurosciences Inc (2017–2017)

Year-by-year capital reinvestment analysis for Minerva Neurosciences Inc. For live market cap and broader valuation context, see Minerva Neurosciences Inc (NERV) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 34.66x $107.19 Million $3.09 Million $52.40K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow